A Randomized, First-in-human, Healthy Volunteer Trial of Sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway Publication 特异性抑制经典补体途径的人源化抗体 Sutimlimab 的首次人体健康志愿者随机试验 Certara2018 年 5 月 8 日
PharmTeX: A LaTeX-based Open-source Platform for Automated Reporting Workflow Publication PharmTeX: A LaTeX-based Open-source Platform for Automated Reporting Workflow Certara2018 年 5 月 1 日
Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain Publication Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain Certara2018 年 5 月 1 日
Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Publication Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Certara2018 年 4 月 9 日
Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Publication Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Certara2018 年 4 月 1 日
Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function Publication Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function Certara2018 年 4 月 1 日
Changing the Game in Drug Development Brochure 改变药物开发的局面 At Certara, we are innovators, dedicated to helping our clients develop new therapies and target…Certara2018 年 3 月 19 日
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Certara2018 年 3 月 15 日
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Certara2018 年 3 月 1 日
A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Publication A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Certara2018 年 2 月 27 日
